How do patients value features of biological medicine in rheumatoid arthritis? A discrete choice experiment

References

• Wolfe F, Hawley D. The long term outcomes of rheumatoid arthritis. Work J Rheumatol. 1998;25:2108–2117.
   PubMed Web of Science ®Google Scholar
• Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology. 2006;46(2):350–357. DOI:10.1093/rheumatology/kel253
   PubMed Web of Science ®Google Scholar
• Uhlig T, Moe RH, Kvien TK. The burden of disease in rheumatoid arthritis. Pharmacoeconomics. 2014;32(9):841–851.
   PubMed Web of Science ®Google Scholar
• Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Research & Therapy. 2008;10(2):R30. DOI:10.1186/ar2383
   PubMed Web of Science ®Google Scholar
• Deodhar AA, Woolf A. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Rheumatology. 1996;35(4):309–322.
   Web of Science ®Google Scholar
• Jamshidi A-R, Banihashemi AT, Roknsharifi S, et al. Estimating the prevalence and disease characteristics of rheumatoid arthritis in Tehran: a WHO-ILAR COPCORD Study (from Iran COPCORD study, Urban Study stage 1). Med J Islam Repub Iran. 2014;28:93.
   PubMedGoogle Scholar
• Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005;4(3):130–136.
   PubMed Web of Science ®Google Scholar
• Alamanos Y, Voulgari PV, Drosos AA. Incidence and Prevalence of Arthritis, Based on the 1987 American College of Rheumatology Criteria: A Systematic Riview. Seminars in arthritis and rheumatism. 2006;36(3):182–188.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Sandoughi M, Moghimi N, et al. Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies. Int J Rheum Dis. 2016;19(11):1056–1062. DOI:10.1111/1756-185X.12809
   PubMed Web of Science ®Google Scholar
• O’dell JR, Wood AJJ. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350(25):2591–2602.
   PubMed Web of Science ®Google Scholar
• Finckh A, Liang MH, Van Herckenrode CM, et al. Long‐term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta‐analysis. Arthritis & Rheumatism. 2006;55(6):864–872. DOI:10.1002/art.22353
   PubMed Web of Science ®Google Scholar
• Augustovski F, Beratarrechea A, Irazola V, et al. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment. Value Health. 2013;16(2):385–393. DOI:10.1016/j.jval.2012.11.007
   PubMed Web of Science ®Google Scholar
• Suarez-Almazor ME, Conner-Spady B, Kendall CJ, et al. Lack of congruence in the ratings of patients’ health status by patients and their physicians. Med Decis Mak. 2001;21(2):113–121. DOI:10.1177/02729890122062361
   PubMed Web of Science ®Google Scholar
• Kassirer JP. Incorporating patients’ preferences into medical decisions. Mass Medical Soc. 1994;330(26):1895–1896.
   Google Scholar
• Toroski M, Kebriaeezadeh A, Esteghamati A, et al. Patient and physician preferences for type 2 diabetes medications: a systematic review. J Diabetes Metab. 2019;18(2):643–656.
   Google Scholar
• Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–413. DOI:10.1016/j.jval.2010.11.013
   PubMed Web of Science ®Google Scholar
• Olsen JA, Smith RD. Theory versus practice: a review of ‘willingness‐to‐pay’in health and health care. Health Econ. 2001;10(1):39–52.
   PubMed Web of Science ®Google Scholar
• Díaz-Torné C, Urruticoechea-Arana A, Ivorra-Cortés J, et al. What matters most to patients and rheumatologists? A discrete choice experiment in rheumatoid arthritis. Adv Ther. 2020;37(4):1–17. DOI:10.1007/s12325-020-01258-5
   Web of Science ®Google Scholar
• Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care. Vol. 11. Dordrecht: Springer Science & Business Media; 2007.
   Google Scholar
• Zartab S, Nikfar S, Karimpour-Fard N, et al. A systematic review of discrete choice experiment studies in rheumatoid arthritis biological medicines. Mediterr J Rheumatol. 2021;32(2):104. DOI:10.31138/mjr.32.2.104
   PubMedGoogle Scholar
• Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13. DOI:10.1016/j.jval.2012.08.2223
   PubMed Web of Science ®Google Scholar
• Orme BK. Getting started with conjoint analysis: strategies for product design and pricing research. Madison: Research Publishers; 2006.
   Google Scholar
• Karyani AK, Sari AA, Woldemichael A. Eliciting preferences for health insurance in Iran using discrete choice experiment analysis. Int J Health Policy Manag. 2019;8(8):488.
   PubMed Web of Science ®Google Scholar
• Hauber AB, González JM, Groothuis-Oudshoorn CGM, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–315. DOI:10.1016/j.jval.2016.04.004
   PubMed Web of Science ®Google Scholar
• Emanuel E, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368(1):6–8.
   PubMed Web of Science ®Google Scholar
• Sacristán JA. Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients. BMC medical informatics and decision making. BMC Med Inform Decis Mak. 2013;13(1):1–8.
   PubMedGoogle Scholar
• Soekhai V, de Bekker-Grob EW, Ellis AR, et al. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37(2):201–226. DOI:10.1007/s40273-018-0734-2
   PubMed Web of Science ®Google Scholar
• Louder AM, Singh A, Saverno K, et al. Patient preferences regarding rheumatoid arthritis therapies: a conjoint analysis. American Health & Drug Benefits. 2016;9(2):84.
   PubMed Web of Science ®Google Scholar
• Hazlewood GS, Bombardier C, Tomlinson G, et al. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment. Rheumatology. 2016;55(11):1959–1968. DOI:10.1093/rheumatology/kew280
   PubMed Web of Science ®Google Scholar
• Alten R, Krüger K, Rellecke J, et al. Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach. Patient Preference Adherence. 2016;10:2217.
   PubMed Web of Science ®Google Scholar
• Postmus D, Mavris M, Hillege H, et al. Incorporating patient preferences into drug development and regulatory decision making: results from a quantitative pilot study with cancer patients, carers, and regulators. Clin Pharmacol Ther. 2016;99(5):548–554. DOI:10.1002/cpt.332
   PubMed Web of Science ®Google Scholar
• Husni ME, Betts KA, Griffith J, et al. Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective. Rheumatol Int. 2017;37(9):1423–1434. DOI:10.1007/s00296-017-3760-z
   PubMed Web of Science ®Google Scholar